Search results
Results from the WOW.Com Content Network
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
Codeine-6-glucuronide (C6G) is a major active metabolite of codeine and may be responsible for as much as 60% of the analgesic effects of codeine. C6G exhibits decreased immunosuppressive effects compared to codeine. [ 1 ]
The CAC is issued to active United States Armed Forces (Regular, Reserves and National Guard) in the Department of Defense and the U.S. Coast Guard; DoD civilians; USCG civilians; non-DoD/other government employees and State Employees of the National Guard; and eligible DoD and USCG contractors who need access to DoD or USCG facilities and/or DoD computer network systems:
In 1967 CAC commenced licence production of a version of the Aermacchi MB-326 optimised for Australian conditions, this programme ending in 1972. In 1971 CAC joined the small number of aircraft manufacturers which have built both fixed- and rotary-winged aircraft, when it began production of a variant of the Bell Kiowa for the Australian Army ...
$5 million. 90%. 5 to 10 business days. Long-term funding for export sales to compete with foreign competitors. CAPLines. $5 million. 85% for loans of $150,000 or less, 75% for loans over $150,000 ...
Van's aircraft designer Richard VanGrunsven designed the RV-7 to replace the RV-6, which was a two-seat side-by-side development of the RV-4. In turn, this was a two-seat tandem version of the single seat RV-3. [7] The RV-7 incorporated many changes resulting from the lessons learned in producing over 2,000 RV-6 kits.
F-7A: Export version of J-7I for Egypt with a new engine WP-7II (涡喷-7乙, WP is short for Wo-Pen, abbreviation for Wo-Lun Pen-Qi, 涡轮喷气, meaning turbojet in Chinese), with mean time between overhaul (MBTO) increased from 100 hours to 200 hours. The CL-2 ranging radar is replaced by more capable Type 222 radar used on J-7II.
Recombinant factor VIIa (rfVIIa) is a form of blood factor VII that has been manufactured via recombinant technology. [4] [5] It is administered via an injection into a vein. [6] [4] [5] It is used to treat bleeding episodes in people who have acquired haemophilia, among other indications. [7] There are several disimilar forms, and biosimilars ...